HCA Healthcare, US40412C1018

HCA Healthcare stock: JPMorgan lifts target to USD 475

Published on 11/21/2026 at 10:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
HCA Healthcare stock received a fresh analyst catalyst after JPMorgan lifted its target. The bank kept a Neutral rating on the shares.

Analyst catalyst shapes HCA outlook

  • JPMorgan updated its model while maintaining a Neutral rating on HCA Healthcare.
  • The revised target adds a new analyst focus for investors assessing the hospital operator.
HCA Healthcare, US40412C1018, Illustration mit AI erstellt.

JPMorgan raised its price target for HCA Healthcare on Wednesday, November 18, according to Markets Insider. Analyst Benjamin Rossi moved the target from USD 425 to USD 475 and kept a Neutral rating on the shares after updating JPMorgan's model.

JPMorgan refreshes its HCA view

The change gives investors a new reference for the bank's assessment of HCA Healthcare during a week marked by renewed attention to hospital-sector earnings risks. The unchanged Neutral rating signals that the higher target did not alter JPMorgan's stated stance on the stock.

HCA Healthcare stock traded at 433.60 euros on Lang & Schwarz at 10:57 CET on Saturday, November 21. The quote reflects the latest Saturday trading indication available during the configured trading window.

HCA Healthcare at a glance

  • Company: HCA Healthcare, Inc.
  • ISIN: US40412C1018
  • Ticker: HCA
  • Latest quote: 433.60 euros on Lang & Schwarz, Saturday, November 21, 2026, at 10:57 CET

Current market reports can be found in the Current market reports section.

More news and analyses on HCA Healthcare stock.

Disclaimer...
en | US40412C1018 | HCA HEALTHCARE | boerse | 70541862 | bgmi